Tapewire

Nasdaq · USD

CRTO

Criteo S.A.

Export transactions ↓
Tapewire entity
291
SEC CIK
0001576427
Parsed reports
363

Last 12 months

Inside the activity.

4 purchase rows · 28 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202533
Dec 202501
Jan 202600
Feb 202604
Mar 202614
Apr 202600
May 202604
Jun 202602
Jul 202600
Aug 202608
Sep 202602
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
March 13, 2023 Filed Mar 14, 2023 20:07 UTC
Clarken MeganDirector · Chief Executive Officer
SaleOrdinary Shares 28 $29.45 $824.60
Disclosure

SEC source: 0001576427-23-000043 · wf-form4_167882441633766.xml · nonDerivative · entry 1

Clarken Megan · CIK 0001795120 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 436,567

F1 · security: The Ordinary Shares may be represented by American Depository Shares, each of which represents One Ordinary Share.

F2 · kind: These securities were automatically sold on the Reporting Person's behalf to fund tax withholding obligations arising from the settlement of a previously-reported security award.

F3 · balance_after: For more information about the equity of the Issuer held by the Reporting Person, please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission ("SEC").

Read SEC document
March 10, 2023 Filed Mar 10, 2023 21:50 UTC
Clarken MeganDirector · Chief Executive Officer
SaleOrdinary Shares 32,822 $30.65 $1,005,994.30
Disclosure

SEC source: 0001576427-23-000041 · wf-form4_167848499968310.xml · nonDerivative · entry 4

Clarken Megan · CIK 0001795120 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 436,595

F1 · security: The Ordinary Shares may be represented by American Depository Shares, each of which represents One Ordinary Share.

F4 · price: The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $30.25 to $30.93 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3 · balance_after: For more information about the equity of the Issuer held by the Reporting Person, please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission ("SEC").

Read SEC document
March 10, 2023 Filed Mar 10, 2023 21:50 UTC
Clarken MeganDirector · Chief Executive Officer
SaleOrdinary Shares 18,627 $30.65 $570,917.55
Disclosure

SEC source: 0001576427-23-000041 · wf-form4_167848499968310.xml · nonDerivative · entry 3

Clarken Megan · CIK 0001795120 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 469,417

F1 · security: The Ordinary Shares may be represented by American Depository Shares, each of which represents One Ordinary Share.

F4 · price: The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $30.25 to $30.93 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3 · balance_after: For more information about the equity of the Issuer held by the Reporting Person, please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission ("SEC").

Read SEC document
March 09, 2023 Filed Mar 10, 2023 21:50 UTC
Clarken MeganDirector · Chief Executive Officer
SaleOrdinary Shares 8,515 $30.89 $263,028.35
Disclosure

SEC source: 0001576427-23-000041 · wf-form4_167848499968310.xml · nonDerivative · entry 2

Clarken Megan · CIK 0001795120 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 488,044

F1 · security: The Ordinary Shares may be represented by American Depository Shares, each of which represents One Ordinary Share.

F2 · price: The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $30.49 to $31.88 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3 · balance_after: For more information about the equity of the Issuer held by the Reporting Person, please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission ("SEC").

Read SEC document
March 09, 2023 Filed Mar 10, 2023 21:50 UTC
Clarken MeganDirector · Chief Executive Officer
SaleOrdinary Shares 42,934 $30.89 $1,326,231.26
Disclosure

SEC source: 0001576427-23-000041 · wf-form4_167848499968310.xml · nonDerivative · entry 1

Clarken Megan · CIK 0001795120 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 496,559

F1 · security: The Ordinary Shares may be represented by American Depository Shares, each of which represents One Ordinary Share.

F2 · price: The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $30.49 to $31.88 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3 · balance_after: For more information about the equity of the Issuer held by the Reporting Person, please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission ("SEC").

Read SEC document
March 07, 2023 Filed Mar 8, 2023 21:17 UTC Exercise / conversionNon-employee Warrant (right to buy) · Derivative 4,846 $0.00 Strike: $18.62 $0.00
Disclosure

SEC source: 0001576427-23-000039 · wf-form4_167831021346880.xml · derivative · entry 12

Balla Nathalie · CIK 0001711277 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,397

Underlying: Ordinary Shares · 4,846 shares

Expires 2029-10-24

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · derivative.exercise_price: The exercise price of the non-employee warrant is 17.44 euros. The U.S. dollar equivalent of the exercise price is $18.62 using the exchange rate as of March 7, 2023 (1.00 = $ 0.9366).

F10 · derivative.exercise_date: Warrant granted on October 24, 2019. One-fourth of the grant vested on the first anniversary of the grant date and an additional 1/16th of the grant vested quarterly thereafter. Warrant is set to expire on October 24, 2029.

F1 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

F3 · balance_after: For more information about the equity of the Issuer held by the Reporting Person, please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission.

Read SEC document
March 07, 2023 Filed Mar 8, 2023 21:17 UTC SaleOrdinary Shares 4,846 $32.03 $155,193.15
Disclosure

SEC source: 0001576427-23-000039 · wf-form4_167831021346880.xml · nonDerivative · entry 8

Balla Nathalie · CIK 0001711277 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,800

F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

F8 · price: The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $32.00 to $32.19 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3 · balance_after: For more information about the equity of the Issuer held by the Reporting Person, please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission.

Read SEC document
March 07, 2023 Filed Mar 8, 2023 21:17 UTC Exercise / conversionOrdinary Shares 4,846 $18.62 $90,232.52
Disclosure

SEC source: 0001576427-23-000039 · wf-form4_167831021346880.xml · nonDerivative · entry 7

Balla Nathalie · CIK 0001711277 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,646

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

F7 · price: The exercise price of the non-employee warrant is 17.44 euros. The U.S. dollar equivalent of the exercise price is $18.62 using the exchange rate as of March 7, 2023 (1.00 = $ 0.9366).

F3 · balance_after: For more information about the equity of the Issuer held by the Reporting Person, please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission.

Read SEC document
March 06, 2023 Filed Mar 8, 2023 21:17 UTC Exercise / conversionNon-employee Warrant (right to buy) · Derivative 12,177 $0.00 Strike: $18.49 $0.00
Disclosure

SEC source: 0001576427-23-000039 · wf-form4_167831021346880.xml · derivative · entry 11

Balla Nathalie · CIK 0001711277 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,243

Underlying: Ordinary Shares · 12,177 shares

Expires 2029-10-24

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_price: The exercise price of the non-employee warrant is 17.44 euros. The U.S. dollar equivalent of the exercise price is $18.49 using the exchange rate as of March 6, 2023 (1.00 = $ 0.9431).

F10 · derivative.exercise_date: Warrant granted on October 24, 2019. One-fourth of the grant vested on the first anniversary of the grant date and an additional 1/16th of the grant vested quarterly thereafter. Warrant is set to expire on October 24, 2029.

F1 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

F3 · balance_after: For more information about the equity of the Issuer held by the Reporting Person, please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission.

Read SEC document
March 06, 2023 Filed Mar 8, 2023 21:17 UTC Exercise / conversionNon-employee Warrant (right to buy) · Derivative 22,400 $0.00 Strike: $20.90 $0.00
Disclosure

SEC source: 0001576427-23-000039 · wf-form4_167831021346880.xml · derivative · entry 10

Balla Nathalie · CIK 0001711277 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Ordinary Shares · 22,400 shares

Expires 2028-10-25

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: The exercise price of the non-employee warrant is 19.71 euros. The U.S. dollar equivalent of the exercise price is $20.90 using the exchange rate as of March 6, 2023 (1.00 = $0.9431).

F9 · derivative.exercise_date: Warrant granted on October 25, 2018. One-fourth of the grant vested on the first anniversary of the grant date and an additional 1/16th of the grant vested quarterly thereafter. Warrant is set to expire on October 25, 2028.

F1 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

F3 · balance_after: For more information about the equity of the Issuer held by the Reporting Person, please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission.

Read SEC document
March 06, 2023 Filed Mar 8, 2023 21:17 UTC Exercise / conversionNon-employee Warrant (right to buy) · Derivative 2,600 $0.00 Strike: $20.90 $0.00
Disclosure

SEC source: 0001576427-23-000039 · wf-form4_167831021346880.xml · derivative · entry 9

Balla Nathalie · CIK 0001711277 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,400

Underlying: Ordinary Shares · 2,600 shares

Expires 2028-10-25

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: The exercise price of the non-employee warrant is 19.71 euros. The U.S. dollar equivalent of the exercise price is $20.90 using the exchange rate as of March 6, 2023 (1.00 = $0.9431).

F9 · derivative.exercise_date: Warrant granted on October 25, 2018. One-fourth of the grant vested on the first anniversary of the grant date and an additional 1/16th of the grant vested quarterly thereafter. Warrant is set to expire on October 25, 2028.

F1 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

F3 · balance_after: For more information about the equity of the Issuer held by the Reporting Person, please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission.

Read SEC document
March 06, 2023 Filed Mar 8, 2023 21:17 UTC SaleOrdinary Shares 12,177 $32.36 $393,986.84
Disclosure

SEC source: 0001576427-23-000039 · wf-form4_167831021346880.xml · nonDerivative · entry 6

Balla Nathalie · CIK 0001711277 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,800

F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

F5 · price: The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $32.00 to $ 32.845 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3 · balance_after: For more information about the equity of the Issuer held by the Reporting Person, please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission.

Read SEC document
March 06, 2023 Filed Mar 8, 2023 21:17 UTC Exercise / conversionOrdinary Shares 12,177 $18.49 $225,152.73
Disclosure

SEC source: 0001576427-23-000039 · wf-form4_167831021346880.xml · nonDerivative · entry 5

Balla Nathalie · CIK 0001711277 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,977

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

F6 · price: The exercise price of the non-employee warrant is 17.44 euros. The U.S. dollar equivalent of the exercise price is $18.49 using the exchange rate as of March 6, 2023 (1.00 = $ 0.9431).

F3 · balance_after: For more information about the equity of the Issuer held by the Reporting Person, please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission.

Read SEC document
March 06, 2023 Filed Mar 8, 2023 21:17 UTC SaleOrdinary Shares 22,400 $32.36 $724,752.00
Disclosure

SEC source: 0001576427-23-000039 · wf-form4_167831021346880.xml · nonDerivative · entry 4

Balla Nathalie · CIK 0001711277 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,800

F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

F5 · price: The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $32.00 to $ 32.845 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3 · balance_after: For more information about the equity of the Issuer held by the Reporting Person, please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission.

Read SEC document
March 06, 2023 Filed Mar 8, 2023 21:17 UTC Exercise / conversionOrdinary Shares 22,400 $20.90 $468,160.00
Disclosure

SEC source: 0001576427-23-000039 · wf-form4_167831021346880.xml · nonDerivative · entry 3

Balla Nathalie · CIK 0001711277 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,200

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

F2 · price: The exercise price of the non-employee warrant is 19.71 euros. The U.S. dollar equivalent of the exercise price is $20.90 using the exchange rate as of March 6, 2023 (1.00 = $0.9431).

F3 · balance_after: For more information about the equity of the Issuer held by the Reporting Person, please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission.

Read SEC document
March 06, 2023 Filed Mar 8, 2023 21:17 UTC SaleOrdinary Shares 2,600 $32.67 $84,952.40
Disclosure

SEC source: 0001576427-23-000039 · wf-form4_167831021346880.xml · nonDerivative · entry 2

Balla Nathalie · CIK 0001711277 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,800

F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

F4 · price: The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $32.51 to $32.77 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3 · balance_after: For more information about the equity of the Issuer held by the Reporting Person, please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission.

Read SEC document
March 06, 2023 Filed Mar 8, 2023 21:17 UTC Exercise / conversionOrdinary Shares 2,600 $20.90 $54,340.00
Disclosure

SEC source: 0001576427-23-000039 · wf-form4_167831021346880.xml · nonDerivative · entry 1

Balla Nathalie · CIK 0001711277 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,400

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

F2 · price: The exercise price of the non-employee warrant is 19.71 euros. The U.S. dollar equivalent of the exercise price is $20.90 using the exchange rate as of March 6, 2023 (1.00 = $0.9431).

F3 · balance_after: For more information about the equity of the Issuer held by the Reporting Person, please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission.

Read SEC document
March 03, 2023 Filed Mar 3, 2023 21:14 UTC
Damon RyanChief Legal Officer
SaleOrdinary Shares 58 $32.22 $1,868.47
Disclosure

SEC source: 0001576427-23-000037 · wf-form4_167787802778952.xml · nonDerivative · entry 2

Damon Ryan · CIK 0001769573 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 163,797

F1 · security: The Ordinary Shares may be represented by American Depository Shares, each of which represents One Ordinary Share.

F2 · kind: These securities were automatically sold on the Reporting Person's behalf to fund tax withholding obligations arising from the settlement of a previously-reported security award.

F3 · balance_after: For more information about the equity of the Issuer held by the Reporting Person, please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission.

Read SEC document
March 03, 2023 Filed Mar 3, 2023 21:14 UTC
Damon RyanChief Legal Officer
SaleOrdinary Shares 66 $32.22 $2,126.19
Disclosure

SEC source: 0001576427-23-000037 · wf-form4_167787802778952.xml · nonDerivative · entry 1

Damon Ryan · CIK 0001769573 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 163,855

F1 · security: The Ordinary Shares may be represented by American Depository Shares, each of which represents One Ordinary Share.

F2 · kind: These securities were automatically sold on the Reporting Person's behalf to fund tax withholding obligations arising from the settlement of a previously-reported security award.

F3 · balance_after: For more information about the equity of the Issuer held by the Reporting Person, please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission.

Read SEC document
February 27, 2023 Filed Mar 1, 2023 21:09 UTC
Clarken MeganDirector · Chief Executive Officer
SaleOrdinary Shares 16,537 $33.47 $553,410.71
Disclosure

SEC source: 0001576427-23-000034 · wf-form4_167770496192899.xml · nonDerivative · entry 2

Clarken Megan · CIK 0001795120 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 539,493

F1 · security: The Ordinary Shares may be represented by American Depository Shares, each of which represents One Ordinary Share.

F2 · kind: These securities were automatically sold on the Reporting Person's behalf to fund tax withholding obligations arising from the settlement of a previously-reported security award.

F3 · balance_after: For more information about the equity of the Issuer held by the Reporting Person, please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission ("SEC").

Read SEC document
February 27, 2023 Filed Mar 1, 2023 21:09 UTC
Clarken MeganDirector · Chief Executive Officer
SaleOrdinary Shares 21,947 $33.47 $734,456.36
Disclosure

SEC source: 0001576427-23-000034 · wf-form4_167770496192899.xml · nonDerivative · entry 1

Clarken Megan · CIK 0001795120 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 556,030

F1 · security: The Ordinary Shares may be represented by American Depository Shares, each of which represents One Ordinary Share.

F2 · kind: These securities were automatically sold on the Reporting Person's behalf to fund tax withholding obligations arising from the settlement of a previously-reported security award.

F3 · balance_after: For more information about the equity of the Issuer held by the Reporting Person, please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission ("SEC").

Read SEC document
February 27, 2023 Filed Mar 1, 2023 21:10 UTC
Damon RyanChief Legal Officer
SaleOrdinary Shares 126 $33.47 $4,216.59
Disclosure

SEC source: 0001576427-23-000035 · wf-form4_167770498864169.xml · nonDerivative · entry 4

Damon Ryan · CIK 0001769573 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 163,921

F1 · security: The Ordinary Shares may be represented by American Depository Shares, each of which represents One Ordinary Share.

F5 · kind: These securities were automatically sold on the Reporting Person's behalf to fund tax withholding obligations arising from the settlement of a previously-reported security award.

F3 · balance_after: For more information about the equity of the Issuer held by the Reporting Person, please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission.

Read SEC document
February 27, 2023 Filed Mar 1, 2023 21:10 UTC
Damon RyanChief Legal Officer
SaleOrdinary Shares 113 $33.47 $3,781.55
Disclosure

SEC source: 0001576427-23-000035 · wf-form4_167770498864169.xml · nonDerivative · entry 3

Damon Ryan · CIK 0001769573 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 164,047

F1 · security: The Ordinary Shares may be represented by American Depository Shares, each of which represents One Ordinary Share.

F5 · kind: These securities were automatically sold on the Reporting Person's behalf to fund tax withholding obligations arising from the settlement of a previously-reported security award.

F3 · balance_after: For more information about the equity of the Issuer held by the Reporting Person, please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission.

Read SEC document
February 27, 2023 Filed Mar 1, 2023 21:10 UTC
Damon RyanChief Legal Officer
SaleOrdinary Shares 17,000 $33.46 $568,803.00
Disclosure

SEC source: 0001576427-23-000035 · wf-form4_167770498864169.xml · nonDerivative · entry 2

Damon Ryan · CIK 0001769573 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 164,160

F1 · security: The Ordinary Shares may be represented by American Depository Shares, each of which represents One Ordinary Share.

F4 · price: The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $33.13 to $33.795 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3 · balance_after: For more information about the equity of the Issuer held by the Reporting Person, please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission.

Read SEC document
February 27, 2023 Filed Mar 1, 2023 21:10 UTC
Damon RyanChief Legal Officer
SaleOrdinary Shares 7,904 $34.02 $268,870.37
Disclosure

SEC source: 0001576427-23-000035 · wf-form4_167770498864169.xml · nonDerivative · entry 1

Damon Ryan · CIK 0001769573 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 181,160

F1 · security: The Ordinary Shares may be represented by American Depository Shares, each of which represents One Ordinary Share.

F2 · price: The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $34.00 to $34.04 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3 · balance_after: For more information about the equity of the Issuer held by the Reporting Person, please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission.

Read SEC document
February 24, 2023 Filed Feb 27, 2023 21:23 UTC SaleOrdinary Shares 10,000 $32.52 $325,200.00
Disclosure

SEC source: 0001576427-23-000028 · wf-form4_167753296424526.xml · nonDerivative · entry 1

Picard Rachel · CIK 0001711285 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,705

F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

F2 · balance_after: For more information about the equity of the Issuer held by the Reporting Person, please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission.

Read SEC document
February 23, 2023 Filed Feb 27, 2023 21:23 UTC
Glickman Sarah JSChief Financial Officer
GrantOrdinary Shares 24,661 $0.00 $0.00
Disclosure

SEC source: 0001576427-23-000029 · wf-form4_167753298949768.xml · nonDerivative · entry 2

Glickman Sarah JS · CIK 0001749338 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 269,335

F1 · security: The Ordinary Shares may be represented by American Depository Shares, each of which currently represents one Ordinary Share.

F4 · shares: On February 24, 2022, the Reporting Person was granted performance-based stock units representing 55,212 shares of the Issuer at the target performance level, which would become eligible to vest based on the achievement of performance goals. On February 23, 2023, the achievement percentage was determined, resulting in 24,661 shares becoming eligible to time-based vesting as follows: 50% of the shares will vest on the two-year anniversary of the grant date, and the remainder will vest in equal portions at the end of each quarter during the two-year period thereafter.

F3 · balance_after: For more information about the equity of the Issuer held by the Reporting Person, please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission ("SEC").

Read SEC document
February 23, 2023 Filed Feb 27, 2023 21:23 UTC
Glickman Sarah JSChief Financial Officer
GrantOrdinary Shares 46,600 $0.00 $0.00
Disclosure

SEC source: 0001576427-23-000029 · wf-form4_167753298949768.xml · nonDerivative · entry 1

Glickman Sarah JS · CIK 0001749338 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 244,674

F1 · security: The Ordinary Shares may be represented by American Depository Shares, each of which currently represents one Ordinary Share.

F2 · shares: The shares are subject to time-based vesting as follows: 50% of the shares will vest on the two-year anniversary of the grant date, and the remainder will vest in equal portions at the end of each quarter during the two-year period thereafter.

F3 · balance_after: For more information about the equity of the Issuer held by the Reporting Person, please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission ("SEC").

Read SEC document
February 23, 2023 Filed Feb 27, 2023 21:24 UTC
Damon RyanChief Legal Officer
GrantOrdinary Shares 15,783 $0.00 $0.00
Disclosure

SEC source: 0001576427-23-000031 · wf-form4_167753305139797.xml · nonDerivative · entry 2

Damon Ryan · CIK 0001769573 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 189,064

F1 · security: The Ordinary Shares may be represented by American Depository Shares, each of which represents One Ordinary Share.

F4 · shares: On February 24, 2022, the Reporting Person was granted performance-based stock units representing 35,336 shares of the Issuer at the target performance level, which would become eligible to vest based on the achievement of performance goals. On February 23, 2023, the achievement percentage was determined, resulting in 15,783 shares becoming eligible to time-based vesting as follows: 50% of the shares will vest on the two-year anniversary of the grant date, and the remainder will vest in equal portions at the end of each quarter during the two-year period thereafter.

F3 · balance_after: For more information about the equity of the Issuer held by the Reporting Person, please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission ("SEC").

Read SEC document
February 23, 2023 Filed Feb 27, 2023 21:24 UTC
Damon RyanChief Legal Officer
GrantOrdinary Shares 31,067 $0.00 $0.00
Disclosure

SEC source: 0001576427-23-000031 · wf-form4_167753305139797.xml · nonDerivative · entry 1

Damon Ryan · CIK 0001769573 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 173,281

F1 · security: The Ordinary Shares may be represented by American Depository Shares, each of which represents One Ordinary Share.

F2 · shares: The shares are subject to time-based vesting as follows: 50% of the shares will vest on the two-year anniversary of the grant date, and the remainder will vest in equal portions at the end of each quarter during the two-year period thereafter.

F3 · balance_after: For more information about the equity of the Issuer held by the Reporting Person, please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission ("SEC").

Read SEC document
February 23, 2023 Filed Feb 27, 2023 21:24 UTC
Clarken MeganDirector · Chief Executive Officer
GrantOrdinary Shares 62,640 $0.00 $0.00
Disclosure

SEC source: 0001576427-23-000030 · wf-form4_167753302587204.xml · nonDerivative · entry 2

Clarken Megan · CIK 0001795120 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 577,977

F1 · security: The Ordinary Shares may be represented by American Depository Shares, each of which represents One Ordinary Share.

F4 · shares: On February 24, 2022, the Reporting Person was granted performance-based stock units representing 140,239 shares of the Issuer at the target performance level, which would become eligible to vest based on the achievement of performance goals. On February 23, 2023, the achievement percentage was determined, resulting in 62,640 shares becoming eligible to time-based vesting as follows: 50% of the shares will vest on the two-year anniversary of the grant date, and the remainder will vest in equal portions at the end of each quarter during the two-year period thereafter.

F3 · balance_after: For more information about the equity of the Issuer held by the Reporting Person, please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission ("SEC").

Read SEC document
February 23, 2023 Filed Feb 27, 2023 21:24 UTC
Clarken MeganDirector · Chief Executive Officer
GrantOrdinary Shares 114,774 $0.00 $0.00
Disclosure

SEC source: 0001576427-23-000030 · wf-form4_167753302587204.xml · nonDerivative · entry 1

Clarken Megan · CIK 0001795120 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 515,337

F1 · security: The Ordinary Shares may be represented by American Depository Shares, each of which represents One Ordinary Share.

F2 · shares: The shares are subject to time-based vesting as follows: 50% of the shares will vest on the two-year anniversary of the grant date, and the remainder will vest in equal portions at the end of each quarter during the two-year period thereafter.

F3 · balance_after: For more information about the equity of the Issuer held by the Reporting Person, please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission ("SEC").

Read SEC document
February 13, 2023 Filed Feb 15, 2023 16:02 UTC Exercise / conversionNon-employee Warrant (right to buy) · Derivative 10,200 $0.00 Strike: $10.34 $0.00
Disclosure

SEC source: 0001576427-23-000007 · wf-form4_167649493455472.xml · derivative · entry 2

de Pesquidoux Hubert · CIK 0001464176 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Ordinary Shares · 10,200 shares

Expires 2023-03-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: Warrant granted on March 6, 2013. One-fourth of the grant vested on the first anniversary of the grant date and an additional 1/16th of the grant vests quarterly thereafter. Warrant is set to expire on March 6, 2023.

F1 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

F3 · balance_after: For more information about the equity of the Issuer held by the Reporting Person, please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission ("SEC").

Read SEC document
February 13, 2023 Filed Feb 15, 2023 16:02 UTC Exercise / conversionOrdinary Shares 10,200 $10.34 $105,468.00
Disclosure

SEC source: 0001576427-23-000007 · wf-form4_167649493455472.xml · nonDerivative · entry 1

de Pesquidoux Hubert · CIK 0001464176 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,881

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

F2 · price: The exercise price of the non-employee warrant is 9.65 euros. The U.S. dollar equivalent of the exercise price is $10.34 using the exchange rate as of February 13, 2023 (1.00 = $0.933).

F3 · balance_after: For more information about the equity of the Issuer held by the Reporting Person, please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission ("SEC").

Read SEC document
January 23, 2023 Filed Jan 24, 2023 21:08 UTC
Glickman Sarah JSChief Financial Officer
SaleOrdinary Shares 2,827 $28.95 $81,835.15
Disclosure

SEC source: 0001576427-23-000002 · wf-form4_167459447558440.xml · nonDerivative · entry 2

Glickman Sarah JS · CIK 0001749338 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 198,074

F1 · security: The Ordinary Shares may be represented by American Depository Shares, each of which currently represents one Ordinary Share.

F2 · kind: These securities were automatically sold on the Reporting Person's behalf to fund tax withholding obligations arising from the settlement of previously-reported security awards.

F3 · balance_after: For more information about the equity of the Issuer held by the Reporting Person, please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission ("SEC").

Read SEC document
January 23, 2023 Filed Jan 24, 2023 21:08 UTC
Glickman Sarah JSChief Financial Officer
SaleOrdinary Shares 2,827 $28.95 $81,835.15
Disclosure

SEC source: 0001576427-23-000002 · wf-form4_167459447558440.xml · nonDerivative · entry 1

Glickman Sarah JS · CIK 0001749338 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 200,901

F1 · security: The Ordinary Shares may be represented by American Depository Shares, each of which currently represents one Ordinary Share.

F2 · kind: These securities were automatically sold on the Reporting Person's behalf to fund tax withholding obligations arising from the settlement of previously-reported security awards.

F3 · balance_after: For more information about the equity of the Issuer held by the Reporting Person, please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission ("SEC").

Read SEC document
December 14, 2022 Filed Dec 15, 2022 16:16 UTC
WARNER JAMESDirector
Exercise / conversionNon-employee Warrant (right to buy) · Derivative 10,200 $0.00 Strike: $10.29 $0.00
Disclosure

SEC source: 0001576427-22-000130 · wf-form4_167113893470134.xml · derivative · entry 6

WARNER JAMES · CIK 0001193080 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Ordinary Shares · 10,200 shares

Expires 2023-03-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: The exercise price of the non-employee warrant is 9.65 euros. The U.S. dollar equivalent of the exercise price is $10.29 using the exchange rate as of December 14, 2022 (1.00 = $1.06587).

F6 · derivative.exercise_date: Warrant granted on March 6, 2013. One-fourth of the grant vested on the first anniversary of the grant date and an additional 1/16th of the grant vested quarterly thereafter. Warrant is set to expire on March 6, 2023.

F1 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

F3 · balance_after: For more information about the equity of the Issuer held by the Reporting Person, please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission.

Read SEC document
December 14, 2022 Filed Dec 15, 2022 16:16 UTC
WARNER JAMESDirector
Exercise / conversionNon-employee Warrant (right to buy) · Derivative 20,400 $0.00 Strike: $10.29 $0.00
Disclosure

SEC source: 0001576427-22-000130 · wf-form4_167113893470134.xml · derivative · entry 5

WARNER JAMES · CIK 0001193080 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Ordinary Shares · 20,400 shares

Expires 2023-02-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: The exercise price of the non-employee warrant is 9.65 euros. The U.S. dollar equivalent of the exercise price is $10.29 using the exchange rate as of December 14, 2022 (1.00 = $1.06587).

F5 · derivative.exercise_date: Warrant granted on February 7, 2013. One-fourth of the grant vested on the first anniversary of the grant date and an additional 1/16th of the grant vested quarterly thereafter. Warrant is set to expire on February 7, 2023.

F1 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

F3 · balance_after: For more information about the equity of the Issuer held by the Reporting Person, please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission.

Read SEC document
December 14, 2022 Filed Dec 15, 2022 16:16 UTC
WARNER JAMESDirector
SaleOrdinary Shares 10,200 $25.90 $264,180.00
Disclosure

SEC source: 0001576427-22-000130 · wf-form4_167113893470134.xml · nonDerivative · entry 4

WARNER JAMES · CIK 0001193080 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,553

F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

F4 · price: The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $25.94 to $25.54 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3 · balance_after: For more information about the equity of the Issuer held by the Reporting Person, please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission.

Read SEC document
December 14, 2022 Filed Dec 15, 2022 16:16 UTC
WARNER JAMESDirector
Exercise / conversionOrdinary Shares 10,200 $10.29 $104,958.00
Disclosure

SEC source: 0001576427-22-000130 · wf-form4_167113893470134.xml · nonDerivative · entry 3

WARNER JAMES · CIK 0001193080 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,753

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

F2 · price: The exercise price of the non-employee warrant is 9.65 euros. The U.S. dollar equivalent of the exercise price is $10.29 using the exchange rate as of December 14, 2022 (1.00 = $1.06587).

F3 · balance_after: For more information about the equity of the Issuer held by the Reporting Person, please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission.

Read SEC document
December 14, 2022 Filed Dec 15, 2022 16:16 UTC
WARNER JAMESDirector
SaleOrdinary Shares 20,400 $25.90 $528,360.00
Disclosure

SEC source: 0001576427-22-000130 · wf-form4_167113893470134.xml · nonDerivative · entry 2

WARNER JAMES · CIK 0001193080 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,553

F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

F4 · price: The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $25.94 to $25.54 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3 · balance_after: For more information about the equity of the Issuer held by the Reporting Person, please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission.

Read SEC document
December 14, 2022 Filed Dec 15, 2022 16:16 UTC
WARNER JAMESDirector
Exercise / conversionOrdinary Shares 20,400 $10.29 $209,916.00
Disclosure

SEC source: 0001576427-22-000130 · wf-form4_167113893470134.xml · nonDerivative · entry 1

WARNER JAMES · CIK 0001193080 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,953

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

F2 · price: The exercise price of the non-employee warrant is 9.65 euros. The U.S. dollar equivalent of the exercise price is $10.29 using the exchange rate as of December 14, 2022 (1.00 = $1.06587).

F3 · balance_after: For more information about the equity of the Issuer held by the Reporting Person, please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission.

Read SEC document
December 12, 2022 Filed Dec 13, 2022 21:16 UTC
Clarken MeganDirector · Chief Executive Officer
SaleOrdinary Shares 3,645 $26.34 $96,011.49
Disclosure

SEC source: 0001576427-22-000128 · wf-form4_167096616775272.xml · nonDerivative · entry 1

Clarken Megan · CIK 0001795120 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 400,563

F1 · security: The Ordinary Shares may be represented by American Depository Shares, each of which represents One Ordinary Share.

F2 · kind: These securities were automatically sold on the Reporting Person's behalf to fund tax withholding obligations arising from the settlement of a previously-reported security award.

F3 · balance_after: For more information about the equity of the Issuer held by the Reporting Person, please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission ("SEC").

Read SEC document
December 06, 2022 Filed Dec 7, 2022 21:06 UTC SaleOrdinary Shares 5,000 $26.90 $134,500.00
Disclosure

SEC source: 0001576427-22-000122 · wf-form4_167044717121942.xml · nonDerivative · entry 2

Picard Rachel · CIK 0001711285 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,705

F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

F2 · balance_after: For more information about the equity of the Issuer held by the Reporting Person, please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission.

Read SEC document
December 05, 2022 Filed Dec 6, 2022 21:08 UTC
Damon RyanChief Legal Officer
SaleOrdinary Shares 67 $27.08 $1,814.36
Disclosure

SEC source: 0001576427-22-000120 · wf-form4_167036085893749.xml · nonDerivative · entry 2

Damon Ryan · CIK 0001769573 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 142,214

F1 · security: The Ordinary Shares may be represented by American Depository Shares, each of which represents One Ordinary Share.

F2 · kind: These securities were automatically sold on the Reporting Person's behalf to fund tax withholding obligations arising from the settlement of a previously-reported security award.

F3 · balance_after: For more information about the equity of the Issuer held by the Reporting Person, please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission.

Read SEC document
December 05, 2022 Filed Dec 6, 2022 21:08 UTC
Damon RyanChief Legal Officer
SaleOrdinary Shares 67 $27.08 $1,814.36
Disclosure

SEC source: 0001576427-22-000120 · wf-form4_167036085893749.xml · nonDerivative · entry 1

Damon Ryan · CIK 0001769573 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 142,281

F1 · security: The Ordinary Shares may be represented by American Depository Shares, each of which represents One Ordinary Share.

F2 · kind: These securities were automatically sold on the Reporting Person's behalf to fund tax withholding obligations arising from the settlement of a previously-reported security award.

F3 · balance_after: For more information about the equity of the Issuer held by the Reporting Person, please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission.

Read SEC document
December 05, 2022 Filed Dec 7, 2022 21:06 UTC SaleOrdinary Shares 7,397 $26.90 $198,979.30
Disclosure

SEC source: 0001576427-22-000122 · wf-form4_167044717121942.xml · nonDerivative · entry 1

Picard Rachel · CIK 0001711285 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,705

F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

F2 · balance_after: For more information about the equity of the Issuer held by the Reporting Person, please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission.

Read SEC document
December 02, 2022 Filed Dec 2, 2022 16:10 UTC GrantOrdinary Shares 7,632 $26.90 $205,300.80
Disclosure

SEC source: 0001576427-22-000118 · wf-form4_167001539890750.xml · nonDerivative · entry 1

de Pesquidoux Hubert · CIK 0001464176 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,681

F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

F2 · kind: The reporting person purchased these securities in accordance with a compensation plan between the Issuer and members of its Board of Directors. As part of its independent director compensation program, the Issuer annually pays additional remuneration to its non-employee directors to facilitate their investment in Company securities. This additional remuneration must be used by the recipient, within a certain period of time, to purchase Issuer securities on the open market. These securities are subject to a time-based shareholding commitment agreed to by the reporting person.

F3 · price: The reported price in Column 4 is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $26.86 to $26.90 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

F4 · balance_after: For more information about the equity of the Issuer held by the Reporting Person, please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission ("SEC").

Read SEC document
December 01, 2022 Filed Dec 2, 2022 21:07 UTC GrantOrdinary Shares 5,800 $26.60 $154,280.00
Disclosure

SEC source: 0001576427-22-000116 · wf-form4_167001520514596.xml · nonDerivative · entry 1

Lalleman Marie · CIK 0001775027 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,816

F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

F2 · kind: The reporting person purchased these securities in accordance with a compensation plan between the Issuer and members of its Board of Directors. As part of its independent director compensation program, the Issuer annually pays additional remuneration to its non-employee directors to facilitate their investment in Company securities. This additional remuneration must be used by the recipient, within a certain period of time, to purchase Issuer securities on the open market. These securities are subject to a time-based shareholding commitment agreed to by the Reporting Person.

F3 · balance_after: For more information about the equity of the Issuer held by the Reporting Person, please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission.

Read SEC document
November 30, 2022 Filed Dec 1, 2022 21:09 UTC GrantOrdinary Shares 11,400 $26.50 $302,100.00
Disclosure

SEC source: 0001576427-22-000114 · wf-form4_166992896310990.xml · nonDerivative · entry 1

Picard Rachel · CIK 0001711285 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 49,102

F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

F2 · kind: The reporting person purchased these securities in accordance with a compensation plan between the Issuer and members of its Board of Directors. As part of its independent director compensation program, the Issuer annually pays additional remuneration to its non-employee directors to facilitate their investment in Company securities. This additional remuneration must be used by the recipient, within a certain period of time, to purchase Issuer securities on the open market. These securities are subject to a time-based shareholding commitment agreed to by the Reporting Person.

F3 · balance_after: For more information about the equity of the issuer held by the reporting person, please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.